Dual Specificity Protein Kinase Market
According to Intent Market Research, the Dual Specificity Protein Kinase Market is expected to grow from USD 64.8 million in 2023 at a CAGR of 24.2% to touch USD 296.0 million by 2030. The Dual Specificity Protein Kinase Market is dominated by key players such as Merck & Co., Inc., Pfizer Inc., Bristol-Myers Squibb, Roche Holding AG, Eli Lilly and Company, Novartis AG, AbbVie Inc., Johnson & Johnson, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline PLC, Amgen Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Biogen Inc..